Fulgent Genetics (NASDAQ: FLGT) reported second quarter EPS of $0.07, $0.25 better than the analyst estimate of $-0.18. Revenue for the quarter came in at $81.8M versus the consensus estimate of $76.21M.
Guidance
Fulgent Genetics sees FY 2025 EPS of $-0.35-$0.00 versus the analyst consensus of $-0.55.
Fulgent Genetics sees FY 2025 revenue of $320.00M versus the analyst consensus of $310.70M.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.